RESUMEN
Titanium and its alloys are often used for long-term implants after their surface treatment. Such surface modification is usually performed to improve biological properties but seldom to increase corrosion resistance. This paper presents research results performed on such metallic materials modified by a variety of techniques: direct voltage anodic oxidation in the presence of fluorides, micro-arc oxidation (MAO), pulse laser treatment, deposition of chitosan, biodegradable Eudragit 100 and poly(4-vinylpyridine (P4VP), carbon nanotubes, nanoparticles of TiO2, and chitosan with Pt (nano Pt) and polymeric dispersant. The open circuit potential, corrosion current density, and potential values were determined by potentiodynamic technique, and microstructures of the surface layers and coatings were characterized by scanning electron microscopy. The results show that despite the applied modifications, the corrosion current density still appears in the region of very low values of some nA/cm2. However, almost all surface modifications, designed principally for the improvement of biological properties, negatively influence corrosion resistance. The reasons for observed effects can vary, such as imperfections and permeability of some coatings or accelerated degradation of biodegradable deposits in simulated body fluids during electrochemical testing. Despite that, all coatings can be accepted for biological applications, and such corrosion testing results are presumed not to be of major importance for their applications in medicine.
RESUMEN
The main aim of the research was to develop a new biocompatible and injectable composite with the potential for application as a bone-to-implant bonding material or as a bone substitute. A composite based on hydroxyapatite, gelatin, and two various types of commercially available transglutaminase (TgBDF/TgSNF), as a cross-linking agent, was proposed. To evaluate the impacts of composite content and processing parameters on various properties of the material, the following research was performed: the morphology was examined by SEM microscopy, the chemical structure by FTIR spectroscopy, the degradation behavior was examined in simulated body fluid, the injectability test was performed using an automatic syringe pump, the mechanical properties using a nanoindentation technique, the surface wettability was examined by an optical tensiometer, and the cell viability was assayed by MTT and LDH. In all cases, a composite paste was successfully obtained. Injectability varied between 8 and 15 min. The type of transglutaminase did not significantly affect the surface topography or chemical composition. All samples demonstrated proper nanomechanical properties with Young's modulus and the hardness close to the values of natural bone. BDF demonstrated better hydrophilic properties and structural stability over 7 days in comparison with SNF. In all cases, the transglutaminase did not lead to cell necrosis, but cellular proliferation was significantly inhibited, especially for the BDF agent.
